Search results
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
Reuters· 6 days agoIndian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on Thursday,...
Is Bristol Myers' Dividend in Danger?
Motley Fool via Yahoo Finance· 4 days agoRising costs and minimal growth pose a problem for Bristol Myers as many of the drugmaker's top drugs, including Eliquis, Revlimid, and Opdivo, are...
Indian drugmaker Cipla beats Q4 profit estimates on strong US demand
KFGO· 5 days agoBENGALURU (Reuters) - Cipla, India's third-largest generic drugmaker by sales, reported fourth-quarter profit above expectations on Friday, driven by strong demand for its products in its key ...
Can multiple myeloma be cured? Treatments and outlook
Medical News Today· 6 days agoConsolidation: This is only if a person is to receive a stem cell transplant. Maintenance: This...
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 6 days agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
Baby Boomers' 14 Least Favorite Drug Brands: Ranked
247wallst.com· 7 days agoBaby boomers are currently one of the oldest demographics. For this reason, they’re also some of the most familiar with medications. But with so many...
Blockbuster Drug Patent Thickets Signal 'Strategic Behavior'
MedPage Today· 2 days agoAn analysis of patent applications for 10 top-selling prescription drugs found that nearly...
Why Is Teva Pharmaceutical Stock Trading Higher On Wednesday? - Teva Pharmaceutical Indus...
Benzinga· 7 days agoWednesday, Teva Pharmaceutical Industries Ltd TEVA and Medincell announced results from the efficacy...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 7 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow
Zacks via Yahoo Finance· 7 days agoDr. Reddy's (RDY) posts better-than-expected fiscal fourth-quarter results on growth in global...